CANCELED - Lecture on Fibromyalgia and Migraines to Public April 7
**As of April 5, 2016, this event has been canceled**
The University of Cincinnati Neuroscience Institute and Department of Psychiatry and Behavioral Neuroscience present a lecture series on "Fibromyalgia and Migraines from 6:30 8:30 p.m. Thursday, April 7, in Room 2108 of the Stetson building, 260 Stetson St.
The program features the following speakers and presentations:
- "Juvenile Fibromyalgia: Whats New? by Tracy Ting, MD, assistant professor, UC Department of Pediatrics; Cincinnati Childrens Hospital Medical Center.
- "Update on Migraine by Vincent Martin, MD, professor of medicine and the director of the Headache and Facial Pain Program at the University of Cincinnati Neuroscience Institute, who has published extensive research on the topic of migraines. Martin is the president of the Ohio Headache Association and vice president of the National Headache Foundation.
Presentation moderator will be Lesley Arnold, MD, professor in the Department of Psychiatry and Behavioral Neuroscience and director of the Womens Health Research Program. Arnold has led numerous studies on the treatment of fibromyalgia.
Lesley Arnold, MD
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.